Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ProShares UltraShort Nasdaq Biotechnology BIS
$19.46
+$0.32 (1.62%)
На 18:01, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
35.64
-
week52low
17.88
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
1.57600000
-
Next Earnings Date
07 мая 2023 г. в 02:05
Описание компании
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
3 ETFs in “Oversold” Territory to Start the Week
ETF Trends
05 дек 2022 г. в 13:58
Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.
2 ETFs to Watch for Outsized Volume on Internet & Inverse Leveraged Biotech
Zacks Investment Research
10 окт 2022 г. в 08:17
Inverse leveraged biotech ETF and internet ETF traded with an outsized volume on Friday.
Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)
Seeking Alpha
08 авг 2022 г. в 18:12
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.